The efficacy of a moisturizer containing panthenol and bisabolol as an adjuvant therapy for treating mild to moderate chronic hand eczema

Phase 4

Completed

• Conditions: Patients with a diagnosis of mild to moderate CHE; moisturizer, panthenol, bisabolol, chronic hand eczema, treatment

• Registration Number: TCTR20211130001
• Lead Sponsor: Faculty of Medicine Siriraj Hospital, Mahidol University, Thailand

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2021-09-30
• Study Start: 2021-11-30
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 56

Inclusion Criteria

1. aged 18 years or older
2. patients with a diagnosis of mild to moderate CHE were included.

Exclusion Criteria

1. patients with severe CHE requiring systemic corticosteroids
2. had disease flare-ups
3. used systemic corticosteroids two weeks prior to the inclusion
4. patients who were pregnant and/or lactating
5. had a history of contact allergy to ingredients in the test product

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The efficacy of a moisturizer containing panthenol and bisabolol baseline, week 2, week 4, week 8, and week 12 The Hand Eczema Severity Index score

Secondary Outcome Measures

Name	Time	Method
The safety of a moisturizer containing panthenol and bisabolol baseline, week 2, week 4, week 8, and week 12 Adverse events,Patient satisfaction week 12 Product satisfaction score